Abstract Library

#3510 Efficacy of 177- Lutetium DOTATATE Peptide Receptor Radionuclide Therapy in patients with metastatic NENs and carcinoid syndrome refractory to somatostatin analogues

Introduction: Optimal management of refractory carcinoid syndrome (RCS) represents an unmet clinical need in patients with metastatic Neuro Endocrine Neoplasms (NEN).

Conference:

Presenting Author: Ratnayake G

Authors: Ratnayake G, Koffas A, Theocharopoulos I, Hayes A, Navalkissoor S,

Keywords: carcinoid syndrome, PRRT,

#1814 Predictors of Outcome in Patients Treated with Peptide Radio-Labelled Receptor Target Therapy (PRRT)

Introduction: The efficacy of PRRT has been demonstrated in patients with well differentiated NETS. The NETTER-01 study demonstrated disease stabilisation or partial response in approximately 80% of patients. However, more studies are needed to identify predictors of response

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Demetriou G

Authors: Demetriou G, Diamantopoulos L, Devakumar H, Popat R, Koffas A,

Keywords: PRRT, Y90, Lu-177,

#1713 Predictive Factors for Survival in Patients with Pancreatic Neuroendocrine Tumours

Introduction: Pancreatic neuroendocrine tumours(pNETs) comprise a heterogeneous group of neoplasms with rising incidence.However,prognosticators at diagnosis(Dx) are limited.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Koffas A

Authors: Koffas A, Demetriou G, Gvozdanovic A, Brooks P, Horan C,

Keywords: pancreatic NETs, prognosis,

#1712 Epidemiological Factors at Diagnosis in a Large Cohort of Patients with Pancreatic Neuroendocrine Tumours

Introduction: Pancreatic neuroendocrine tumours(pNETs) are among the most frequent NETs with an increasing incidence.However,recent epidemiological data reports are limited.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Koffas A

Authors: Koffas A, Demetriou G, Gvozdanovic A, Brooks P, Horan C,

Keywords: pancreatic neuroendocrine tumors, epidemiology,

#1698 Assessment of Small Intestinal Bacterial Overgrowth (SIBO) in NET Patients

Introduction: SIBO is not uncommon in NETs. Hydrogen Breath testing (HBT) using glucose may be more sensitive to proximal SIBO as glucose rarely reaches the colon. Many NET patients are likely to have distal SIBO however, as factors such as ileocecal valve removal apparently increase distal SIBO risk. Thus glucose BT alone may limit sensitivity for detecting SIBO in some NET diagnoses.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Whyand T, Koffas A, Toumpanakis C, Mandair D, Caplin M,

Keywords: nets, sibo, dysbiosis, ,